Cited by 237Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder ResearchNeuroscience and Neuropharmacology Research

The emerging role of SHANK genes in neuropsychiatric disorders

Guilmatre, Audrey, Huguet, Guillaume, Delorme, Richard, Bourgeron, Thomas·2014·Developmental Neurobiology

Abstract

The genetic heterogeneity of neuropsychiatric disorders is high, but some pathways emerged, notably synaptic functioning. A large number of mutations have been described in genes such as neuroligins, neurexins, and SHANK that play a role in the formation and the maintenance of synapses. This review focuses on the disorders associated with mutations in SHANK3 and the other members of its family, SHANK1 and SHANK2. SHANKs are scaffolding proteins of the postsynaptic density of glutamatergic synapses. SHANK3 has been described in the Phelan‐McDermid syndrome (PMS), but also in autism spectrum disorders (ASD) and schizophrenia associated to moderate to severe intellectual disability (ID) and poor language. The evolution of patients with PMS includes symptoms of bipolar disorder and regression. SHANK2 has been identified in patients with ASD with mild to severe ID. SHANK1 has been associated with high‐functioning autism in male patients, while carrier females only display anxiety and shyness. Finally, based on neuropathological findings in animal models and patients, a possible role of SHANK in Alzheimer's disease is discussed. Altogether, this review describes the clinical trajectories associated with different mutations of the SHANK genes and provides information to further investigate the role of the SHANK genes in neuropsychiatric disorders. © 2013 Wiley Periodicals, Inc. Develop Neurobiol 74: 113–122, 2014

Integrity signals

Registry

Crossref · 10.1002/dneu.22128

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Guilmatre, A., Huguet, G., Delorme, R., & Bourgeron, T.
Affiliations
Centre National de la Recherche Scientifique (FR)
Venue
Developmental Neurobiology
Publisher
Wiley
Published
2013-10-07
Volume
74
Issue
2
Pages
113-122
ISSN
  • 1932-8451 (ISSN-L)
  • 1932-846X
OpenAlex
W1606006491
Cited by
237
References
63
Citations by year
2026: 6 · 2025: 10 · 2024: 17 · 2023: 14 · 2022: 14 · 2021: 26 · 2020: 14 · 2019: 18 · 2018: 20 · 2017: 30 · 2016: 25 · 2015: 27 · 2014: 16
FWCI
2.78
Type
journal article
Language
en
Open access
closed
Locations
  • Developmental Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • ANR (ANR-08-MNPS-037-01-SynGen)
  • Bettencourt-Schueller Foundation
  • CNRS
  • Cognacq Jay Foundation
  • Conny-Maeva Charitable Foundation
  • Fondation de France
  • Institut Pasteur
  • Neuron-ERANET (EUHF-AUTISM)
  • Orange Foundation
  • University Paris-Diderot
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
SHANK3, Shank1, Shank2, neuropsychiatric disorders, Phelan-McDermid syndrome, autism spectrum disorder, schizophrenia, intellectual disability, bipolar disorder, postsynaptic density, synaptic function, neuroligins, neurexin, Alzheimer's disease, genetic mutations, clinical trajectories
MeSH terms
Alzheimer Disease, Animals, Mental Disorders, Bipolar Disorder, Child Development Disorders, Pervasive, Chromosome Deletion, Chromosomes, Human, Pair 22, Humans, Mutation, Nerve Tissue Proteins, Schizophrenia, Chromosome Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review